Price Action Alert: Is Buying Stock Like Biostar Pharmaceuticals Inc After Such Increase Winning Strategy?

Price Action Alert: Is Buying Stock Like Biostar Pharmaceuticals Inc After Such Increase Winning Strategy?

The stock of Biostar Pharmaceuticals Inc (NASDAQ:BSPM) is a huge mover today! The stock increased 11.05% or $0.38 on November 23, hitting $3.82. About 855,492 shares traded hands or 8.54% up from the average. Biostar Pharmaceuticals Inc (NASDAQ:BSPM) has risen 161.64% since April 22, 2016 and is uptrending. It has outperformed by 156.23% the S&P500.
The move comes after 5 months positive chart setup for the $10.13 million company. It was reported on Nov, 24 by Barchart.com. We have $3.97 PT which if reached, will make NASDAQ:BSPM worth $405,200 more.

Analysts await Biostar Pharmaceuticals Inc (NASDAQ:BSPM) to report earnings on April, 13.

According to Zacks Investment Research, “BioStar Pharmaceuticals, Inc., through its wholly-owned subsidiary, Shaanxi Aoxing Pharmaceutical Co., Ltd., develops, manufactures and markets pharmaceutical and medical nutrient products for a variety of diseases and conditions. The Company’s most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar manufactures two broad-based over-the-counter products, two prescription-based pharmaceuticals and ten nutrients. The Company has adopted international standards and is in the process of applying for three patents. It also operates an herbal medicine planting base which provides it with many of its needed materials at a significantly lower cost than purchasing from third parties, and eliminates most needs for transportation.”

More notable recent Biostar Pharmaceuticals Inc (NASDAQ:BSPM) news were published by: Prnewswire.com which released: “Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months …” on November 21, 2016, also Prnewswire.com with their article: “Biostar Pharmaceuticals, Inc. Announces Its Quarterly Results for Three Months …” published on August 22, 2016, Prnewswire.com published: “Biostar Pharmaceuticals Completes Previously Announced Registered Direct Financing” on October 18, 2016. More interesting news about Biostar Pharmaceuticals Inc (NASDAQ:BSPM) were released by: Marketwatch.com and their article: “Plus the latest data from Realtor.com on 21 home markets across the US” published on December 27, 2010 as well as Benzinga.com‘s news article titled: “Crazy Stock Move Of The Day: Biostar Pharmaceuticals” with publication date: June 08, 2016.

BSPM Company Profile

Biostar Pharmaceuticals, Inc. (Biostar), incorporated on March 27, 2007, is a holding company. The Company, through its subsidiary, Shaanxi Biostar Biotech, Ltd. (Shaanxi Biostar), and its variable interest entities (VIEs), Shaanxi Aoxing Pharmaceutical Co., Ltd. (Aoxing Pharmaceutical) and Shaanxi Weinan Huaren Pharmaceuticals Ltd. (Shaanxi Weinan), develops, makes and markets pharmaceutical products for various diseases and conditions in the People’s Republic of China (PRC or China). The Firm offers over-the-counter (OTC) products and prescription pharmaceuticals. The Company’s products are derived from medicinal herbs that are either grown at its own facility or purchased from its suppliers. The Company’s products are sold in approximately 30 provinces in the PRC through a network of over 60 distributors and through approximately 230 sales people.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment